OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats
Cui Liu, Yan Xue, Meifang Liu, et al.
Journal of Neurochemistry (2018) Vol. 147, Iss. 3, pp. 380-394
Open Access | Times Cited: 28
Cui Liu, Yan Xue, Meifang Liu, et al.
Journal of Neurochemistry (2018) Vol. 147, Iss. 3, pp. 380-394
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Meifang Liu, Yan Xue, Cui Liu, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 55
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2025)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2025)
Open Access
Deficiency of orexin receptor type 1 in dopaminergic neurons increases novelty-induced locomotion and exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2025) Vol. 12
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2025) Vol. 12
Open Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Modelling orexinergic system in ageing in the African turquoise killifish
Maria Raggio, Iván Conte, Paolo de Girolamo, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Open Access
Maria Raggio, Iván Conte, Paolo de Girolamo, et al.
Biogerontology (2025) Vol. 26, Iss. 2
Open Access
α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson’s Disease Models
Mingxia Bi, Xixun Du, Qian Jiao, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1682-1691
Closed Access | Times Cited: 34
Mingxia Bi, Xixun Du, Qian Jiao, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1682-1691
Closed Access | Times Cited: 34
GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice
Cui Liu, Wen-Hong Liu, Wu Yang, et al.
Neuropharmacology (2024) Vol. 252, pp. 109946-109946
Open Access | Times Cited: 3
Cui Liu, Wen-Hong Liu, Wu Yang, et al.
Neuropharmacology (2024) Vol. 252, pp. 109946-109946
Open Access | Times Cited: 3
Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
Orexins role in neurodegenerative diseases: From pathogenesis to treatment
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21
Orexinergic System in Neurodegenerative Diseases
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Qinqin Wang, Fei Cao, Yili Wu
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 16
Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson’s disease
Ying Wang, An-Qi Chen, Yan Xue, et al.
AJP Cell Physiology (2019) Vol. 317, Iss. 4, pp. C800-C812
Open Access | Times Cited: 18
Ying Wang, An-Qi Chen, Yan Xue, et al.
AJP Cell Physiology (2019) Vol. 317, Iss. 4, pp. C800-C812
Open Access | Times Cited: 18
Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats
Patrycja Orlowska‐Feuer, Magdalena K. Smyk, Katarzyna Palus‐Chramiec, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Patrycja Orlowska‐Feuer, Magdalena K. Smyk, Katarzyna Palus‐Chramiec, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Hypocretin (Orexin) Replacement Therapies
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
Erica Seigneur, Luı́s de Lecea
Medicine in Drug Discovery (2020) Vol. 8, pp. 100070-100070
Open Access | Times Cited: 12
Exploring the Role of Orexin-A Neuropeptide in Parkinson's Disease: A Systematic Review and Meta-Analysis
Vinay Suresh, Mainak Bardhan, Shankhaneel Ghosh, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 242, pp. 108320-108320
Closed Access | Times Cited: 1
Vinay Suresh, Mainak Bardhan, Shankhaneel Ghosh, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 242, pp. 108320-108320
Closed Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice
Kang Bian, Cui Liu, Ying Wang, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136291-136291
Closed Access | Times Cited: 8
Kang Bian, Cui Liu, Ying Wang, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136291-136291
Closed Access | Times Cited: 8
Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta
Cui Liu, Nan-Wei Kang, Ying Wang, et al.
Neuropharmacology (2022) Vol. 219, pp. 109235-109235
Closed Access | Times Cited: 4
Cui Liu, Nan-Wei Kang, Ying Wang, et al.
Neuropharmacology (2022) Vol. 219, pp. 109235-109235
Closed Access | Times Cited: 4
Ghrelin Reduces A-Type Potassium Currents in Dopaminergic Nigral Neurons via the PLC/PKCδ Pathway
Bao Xue, Chen Li, Xiaoli Chang, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 8, pp. 947-950
Open Access | Times Cited: 4
Bao Xue, Chen Li, Xiaoli Chang, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 8, pp. 947-950
Open Access | Times Cited: 4
Targeting the lateral hypothalamus with short hairpin RNAs reduces habitual behaviour following extended instrumental training in rats
Asena Bingul, Sam Merlin, Pascal Carrive, et al.
Neurobiology of Learning and Memory (2022) Vol. 193, pp. 107657-107657
Closed Access | Times Cited: 3
Asena Bingul, Sam Merlin, Pascal Carrive, et al.
Neurobiology of Learning and Memory (2022) Vol. 193, pp. 107657-107657
Closed Access | Times Cited: 3
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review
Kausar Raheel, Qi Rui See, Veronica Munday, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 9, pp. 389-412
Open Access
Kausar Raheel, Qi Rui See, Veronica Munday, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 9, pp. 389-412
Open Access
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2024)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
(2024)
Open Access
Habitual behaviour associated with exposure to high-calorie diet is prevented by an orexin-receptor-1 antagonist
Sam Merlin, Teri M. Furlong
Addiction Neuroscience (2022) Vol. 4, pp. 100036-100036
Open Access | Times Cited: 1
Sam Merlin, Teri M. Furlong
Addiction Neuroscience (2022) Vol. 4, pp. 100036-100036
Open Access | Times Cited: 1
Deficiency of Orexin Receptor Type 1 in Dopaminergic Neurons Increases Novelty-Induced Locomotion and Exploration
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2023)
Open Access
Xing Xiao, Gagik Yeghiazaryan, Fynn Eggersmann, et al.
eLife (2023)
Open Access
